The Patent Finder

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Othair Prothena Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 17/925,813, filed Nov 16, 2022. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,945,849Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
In force
 · Medium confidence
Othair Prothena LimitedIn force
Medium confidence
US 11,952,406Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
In force
 · Medium confidence
Othair Prothena LimitedIn force
Medium confidence
US 11,965,005Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
In force
 · Medium confidence
Othair Prothena LimitedIn force
Medium confidence
US 12,247,056Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
In force
 · Medium confidence
Othair Prothena LimitedIn force
Medium confidence
Application 17/925,813Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
Pending
Not granted
Prothena Biosciences Inc.PendingNot granted
Application 19/064,783Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
Pending
Not granted
Othair Prothena LimitedPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Othair Prothena Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited